Paris, France

Schnupf Pamela

This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique-Hopitaux De Paris, Fondation Imagine, Institut Pasteur. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Schnupf Pamela

Introduction

Schnupf Pamela is a notable inventor based in Paris, France. He has made significant contributions to the field of microbiology, particularly in the culturing of segmented filamentous bacteria. His innovative methods have the potential to advance research in various biological applications.

Latest Patents

Schnupf Pamela holds a patent for a method of culturing segmented filamentous bacteria in vitro. The patent describes an in vitro method that involves co-culturing a segmented filamentous bacterium strain with a eukaryotic host cell. This culture is performed at an oxygen level inferior to 5% in a rich tissue culture liquid medium containing bacterial medium components, including iron. Additionally, the invention includes methods for genetically modifying a segmented filamentous bacterium strain, which involves culturing the strain in vitro.

Career Highlights

Throughout his career, Schnupf Pamela has worked with esteemed organizations such as Fondation Imagine and Assistance Publique-Hopitaux De Paris. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Schnupf Pamela has collaborated with notable colleagues, including Bikard David and Cerf Bensussan Nadine. These partnerships have further enriched his research and innovation efforts.

Conclusion

Schnupf Pamela's contributions to the field of microbiology through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to influence research in culturing bacteria and genetic modification.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…